...
首页> 外文期刊>World Journal of Gastroenterology >First-line eradication of H pylori infection in Europe: A meta-analysis based on congress abstracts, 1997-2004.
【24h】

First-line eradication of H pylori infection in Europe: A meta-analysis based on congress abstracts, 1997-2004.

机译:在欧洲一线根除幽门螺杆菌感染:一项基于会议摘要的荟萃分析,1997-2004年。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: To meta-analyse the European abstracts presented between 1997-2004 at the European H pylori Study Group, United European Gastroenterology Week meetings and World Congresses of Gastroenterology. METHODS: The abstracts of randomized/controlled prospective studies were classified into groups based on first-line eradication schedules. The quality of the abstracts was checked by a validated score system. The pooled eradication rates (PER) and combined odds ratios (OR) were calculated and compared with the published meta-analyses. RESULTS: The PER of proton pump inhibitor-based (PPI) one week triple therapies was 81.4% (confidence interval, 95% CI: 78.5-84.5). Ranitidine bismuth citrate-based (RBC) triple regimens have an efficiency rate of 78.5% (95% CI: 70.5%-84.3%) (P = 0.28 vs PPI). The OR for PPI effect vs RBC regimens was 1.1 (95% CI: 0.92-1.30). H(2) receptor antagonist-based triple therapies achieved 64.1% (95% CI: 52.6-75.6) (P = 0.02 < 0.05 vs PPI), the OR vs PPI regimens was 1.55 (95% CI: 0.72-3.78). PPI-based double combinations were less efficient than triple regimens (PER: 55.0%, OR: 4.90, 95% CI: 2.36-9.70). Quadruple regimens were successful in 82.6% (95% CI: 76.0-89.7), the OR vs triple therapies was 0.80 (0.62-1.03). Clarithromycin + amoxicillin or nitroimidazole combinations were efficient in 80.5% (95% CI: 77.2-84.2) and 83.8% (95% CI: 81.7-85.9), respectively. Amoxicillin + nitromidazole therapies eradicated the infection in 73.5% (66.6-78.5) (P = 0.01 < 0.05 vs clarithromycin-based regimens). CONCLUSION: PPI/RBC-based triple therapies achieved comparable results with the meta-analyses. H(2)-receptor antagonists and PPI-based double combinations were less efficient. Triple and quadruple regimens were equally effective. Clarithromycin + either amoxicillin or nitroimidazole containing regimens were more effective than amoxicillin + nitroimidazole combinations. High quality congress abstracts constitutes a valuable pool of data which is suitable for meta-analytical workup.
机译:目的:对1997-2004年间在欧洲幽门螺杆菌研究组,联合欧洲胃肠病学周会议和世界胃肠病学大会上发表的欧洲摘要进行荟萃分析。方法:根据一线根除时间表,将随机/对照前瞻性研究的摘要分为几类。摘要的质量由经过验证的评分系统检查。计算合并的根除率(PER)和综合优势比(OR),并将其与已发表的荟萃分析进行比较。结果:基于质子泵抑制剂(PPI)的三周疗法的PER为81.4%(置信区间,95%CI:78.5-84.5)。基于雷尼替丁柠檬酸铋铋(RBC)的三联疗法的有效率为78.5%(95%CI:70.5%-84.3%)(P = 0.28 vs PPI)。 PPI效果与RBC方案的OR值为1.1(95%CI:0.92-1.30)。基于H(2)受体拮抗剂的三联疗法达到64.1%(95%CI:52.6-75.6)(P = 0.02 <0.05 vs PPI),OR vs PPI方案为1.55(95%CI:0.72-3.78)。基于PPI的双重组合疗效不如三联方案(PER:55.0%,OR:4.90,95%CI:2.36-9.70)。四联疗法成功率为82.6%(95%CI:76.0-89.7),OR或三联疗法为0.80(0.62-1.03)。克拉霉素+阿莫西林或硝基咪唑组合分别有效达80.5%(95%CI:77.2-84.2)和83.8%(95%CI:81.7-85.9)。阿莫西林+硝基咪唑疗法根除了73.5%(66.6-78.5)的感染率(与基于克拉霉素的方案相比,P = 0.01 <0.05)。结论:基于PPI / RBC的三联疗法与荟萃分析取得了可比的结果。 H(2)受体拮抗剂和基于PPI的双重组合效率较低。三重和四重方案同样有效。克拉霉素+阿莫西林或含硝基咪唑的方案比阿莫西林+硝基咪唑的组合更有效。高质量的会议摘要构成了有价值的数据池,适合进行荟萃分析工作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号